Nivolumab plus ipilimumab: a potential regimen to rewrite treatment guidelines for ESCC

por Luo, Yuejun, Sun, Nan, He, Jie
Publicado 2022

The potential role of N(7)-methylguanosine (m7G) in cancer

por Luo, Yuejun, Yao, Yuxin, Wu, Peng, Zi, Xiaohui, Sun, Nan, He, Jie
Publicado 2022

RNA N (6)‐methyladenosine modification in the lethal teamwork of cancer stem cells and the tumor immune microenvironment: Current landscape and therapeutic potential

por Zhang, Zhihui, Zhang, Chaoqi, Luo, Yuejun, Zhang, Guochao, Wu, Peng, Sun, Nan, He, Jie
Publicado 2021

Making the Best Use of Available Weapons for the Inevitable Rivalry-Resistance to EGFR-TKIs

por Li, Dongyu, Wang, Jingnan, Liu, Chengming, Luo, Yuejun, Xu, Haiyan, Wang, Yan, Sun, Nan, He, Jie
Publicado 2023

Comprehensive molecular analyses of a TNF family-based signature with regard to prognosis, immune features, and biomarkers for immunotherapy in lung adenocarcinoma

por Zhang, Chaoqi, Zhang, Guochao, Sun, Nan, Zhang, Zhen, Zhang, Zhihui, Luo, Yuejun, Che, Yun, Xue, Qi, He, Jie
Publicado 2020

Identification of a costimulatory molecule-based signature for predicting prognosis risk and immunotherapy response in patients with lung adenocarcinoma

por Zhang, Chaoqi, Zhang, Zhihui, Sun, Nan, Zhang, Zhen, Zhang, Guochao, Wang, Feng, Luo, Yuejun, Che, Yun, He, Jie
Publicado 2020

Tumor‐infiltrating CD8(+) T cell is prognostic and predicts adjuvant chemotherapy benefit in patients with limited‐stage small cell esophageal carcinoma

por Zhang, Zhihui, Zhang, Chaoqi, Zhang, Guochao, Luo, Yuejun, Xue, Liyan, Zeng, Qingpeng, Wu, Peng, Wang, Lide, Sun, Nan, He, Jie
Publicado 2021

Tumor Necrosis Factor Family Member Profile Predicts Prognosis and Adjuvant Chemotherapy Benefit for Patients With Small-Cell Lung Cancer

por Zhang, Zhihui, Wu, Peng, Zhang, Chaoqi, Luo, Yuejun, Zhang, Guochao, Zeng, Qingpeng, Wang, Lide, Yang, Zhaoyang, Sun, Nan, He, Jie
Publicado 2021

Single-cell analysis reveals the potential mechanisms of pyrotinib resistance in non-small cell lung cancer

por Wang, Xinfeng, Li, Yuan, Jin, Runsen, Zheng, Sufei, Luo, Yuejun, Wu, Peng, Wang, Zhanyu, Yao, Yuxin, Sun, Nan, He, Jie
Publicado 2023

Costimulatory molecule expression profile as a biomarker to predict prognosis and chemotherapy response for patients with small cell lung cancer

por Wu, Peng, Zhang, Zhihui, Yang, Zhaoyang, Zhang, Chaoqi, Luo, Yuejun, Zhang, Guochao, Wang, Lide, Xue, Qi, Sun, Nan, He, Jie
Publicado 2022

Identification of a Prognostic Immune Signature for Esophageal Squamous Cell Carcinoma to Predict Survival and Inflammatory Landscapes

por Zhang, Chaoqi, Luo, Yuejun, Zhang, Zhen, Zhang, Zhihui, Zhang, Guochao, Wang, Feng, Che, Yun, Fang, Lingling, Zhang, Yi, Sun, Nan, He, Jie
Publicado 2020

The combination of novel immune checkpoints HHLA2 and ICOSLG: A new system to predict survival and immune features in esophageal squamous cell carcinoma

por Zhang, Chaoqi, Wang, Feng, Sun, Nan, Zhang, Zhen, Zhang, Guochao, Zhang, Zhihui, Luo, Yuejun, Che, Yun, Cheng, Hong, Li, Jiagen, He, Jie
Publicado 2020

A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma

por Sun, Nan, Luo, Yuejun, Zheng, Bo, Zhang, Zhihui, Zhang, Chaoqi, Zhang, Zhen, Zhang, Guochao, Tan, Fengwei, Xue, Qi, Gao, Shugeng, He, Jie
Publicado 2022

Expression Analysis and Serodiagnostic Potential of Microneme Proteins 1 and 3 in Eimeria stiedai

por Wei, Wenrui, Shen, Nengxing, Xiao, Jie, Tao, Yuanyuan, Luo, Yuejun, Angel, Christiana, Gu, Xiaobin, Xie, Yue, He, Ran, Jing, Bo, Peng, Xuerong, Yang, Guangyou
Publicado 2020

m(6)A regulators as predictive biomarkers for chemotherapy benefit and potential therapeutic targets for overcoming chemotherapy resistance in small-cell lung cancer

por Zhang, Zhihui, Zhang, Chaoqi, Yang, Zhaoyang, Zhang, Guochao, Wu, Peng, Luo, Yuejun, Zeng, Qingpeng, Wang, Lide, Xue, Qi, Zhang, Yi, Sun, Nan, He, Jie
Publicado 2021

Comprehensive analyses of N (6)‐methyladenosine‐related long noncoding RNA profiles with prognosis, chemotherapy response, and immune landscape in small cell lung cancer

por Luo, Yuejun, Zhang, Zhihui, Zheng, Bo, Wu, Peng, Zhang, Guochao, Wang, Lide, Zeng, Qingpeng, Yang, Zhaoyang, Xue, Liyan, Zeng, Hua, Tan, Fengwei, Xue, Qi, Gao, Shugeng, Sun, Nan, He, Jie
Publicado 2022

m(6)A regulator expression profile predicts the prognosis, benefit of adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in patients with small-cell lung cancer

por Zhang, Zhihui, Zhang, Chaoqi, Luo, Yuejun, Wu, Peng, Zhang, Guochao, Zeng, Qingpeng, Wang, Lide, Yang, Zhaoyang, Xue, Liyan, Zheng, Bo, Zeng, Hua, Tan, Fengwei, Xue, Qi, Gao, Shugeng, Sun, Nan, He, Jie
Publicado 2021

An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer

por Zhang, Zhihui, Luo, Yuejun, Zhang, Chaoqi, Wu, Peng, Zhang, Guochao, Zeng, Qingpeg, Wang, Lide, Xue, Liyan, Yang, Zhaoyang, Zeng, Hua, Zheng, Bo, Tan, Fengwei, Xue, Qi, Gao, Shugeng, Sun, Nan, He, Jie
Publicado 2021

The landscape of m(6)A regulators in small cell lung cancer: molecular characteristics, immuno-oncology features, and clinical relevance

por Zhang, Chaoqi, Zhang, Zhihui, Zhang, Zhen, Luo, Yuejun, Wu, Peng, Zhang, Guochao, Xue, Liyan, Zeng, Qingpeng, Wang, Lide, Yang, Zhaoyang, Zeng, Hua, Zheng, Bo, Tan, Fengwei, Xue, Qi, Gao, Shugeng, Sun, Nan, He, Jie
Publicado 2021

An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamo...

por Zhang, Chaoqi, Zhang, Guochao, Sun, Nan, Zhang, Zhen, Xue, Liyan, Zhang, Zhihui, Yang, Haijun, Luo, Yuejun, Zheng, Xiaoli, Zhang, Yonglei, Yuan, Yufen, Lei, Ruixue, Yang, Zhaoyang, Zheng, Bo, Wang, Le, Che, Yun, Wang, Feng, Wang, Sihui, Gao, Shugeng, Xue, Qi, Zhang, Yi, He, Jie
Publicado 2020